AlphaYouJH
Congress trade
Sen. John Hoeven (R-ND) sold $100K-$250K of AbbVie Inc. (ABBV) stock
John Hoeven, U.S. Senator (R-ND), disclosed a sale of AbbVie Inc. (ABBV) stock worth $100K-$250K in a STOCK Act filing on Jan 25, 2017.
The trade happened on Jan 20, 2017, 5 days before it was made public.
ABBV has moved +329.9% since the trade date, from $61.15 to $262.90 (Oct 2, 2026 close).
- Traded
- Jan 20, 2017
- Disclosed
- Jan 25, 2017
- Filing delay
- 5 days
- Price since
- +329.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (14)
- BuyCSCO$100K-$250KJan 25, 2017
- SellJNJ$100K-$250KJan 25, 2017
- BuyKO$100K-$250KJan 25, 2017
- BuyPEP$100K-$250KJan 25, 2017
- BuyPG$100K-$250KJan 25, 2017
- SellAMGN$50K-$100KJan 25, 2017
- SellBMY$50K-$100KJan 25, 2017
- BuyINTC$50K-$100KJan 25, 2017
- SellMRK$50K-$100KJan 25, 2017
- SellPFE$50K-$100KJan 25, 2017
- BuyT$50K-$100KJan 25, 2017
- BuyVFC$50K-$100KJan 25, 2017
- BuyVZ$50K-$100KJan 25, 2017
- BuyWTW$50K-$100KJan 25, 2017
More ABBV insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.